November 14, 2018 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Feature Articles
NIAID Sets Interim Paylines for Most Activity Codes
We’ve posted interim paylines for most applicable activity codes at NIAID Paylines, including training, fellowship, small business, and small research grant awards.
Opportunities and Resources
Two New FOAs Related to Vaccine and Treatment Evaluation Units
For more than five decades, NIAID’s Vaccine and Treatment Evaluation Units have been a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases.
Further research is required to translate in vitro findings about antibody-dependent cellular cytotoxicity and antibody-dependent cell-mediated phagocytosis to in vivo efficacy.
Antibodies generated by an anti-opioid vaccine could bind to a target opioid and prevent it from crossing the blood-brain barrier and trafficking to the brain.
Apply now for a cooperative agreement award to develop biomarkers/bioassays, techniques, or devices for use in the civilian population.
We expect successful offerors to provide data-driven, production-level, sustainable computational platforms to enable sharing and access to data, portable computational tools, and standards that support interoperability for the infectious diseases research community.
In The News
A Medley of Updates for Small Business Grantees
A concise rundown of the latest news impacting small business concerns seeking small business innovation research or small business technology transfer funding from NIH and NIAID.
Applicants eligible for continuous submission who send AIDS-related applications on or before February 7, 2019, will be on time for the May 2019 Advisory Council round.
NIH seeks feedback on the definition of Scientific Data and general requirements for Data Management and Sharing Plans.
Advice Corner
New Videos Put the “See” in CSR
Learn about the role of scientific review officers, review meeting proceedings, factors reviewers look for in applications, review criteria, scoring of applications, and more.
Reader Questions
- “Can an investigator be listed as a PI on more than one scientifically distinct application in response to an RFA?”
- “If my application is submitted in one fiscal year, but the grant is not awarded until the next fiscal year, under which fiscal year is the award classified?”
New Funding Opportunities
- PA-19-068, Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
- RFA-AI-18-053, Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)
- PA-19-067, Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
- PA-19-066, Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
- PA-19-042, Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)
- PA-19-050, Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)
- RFA-CA-19-015, Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
- RFA-OD-18-102, Limited Competition: Restoring Research Resources Lost or Damaged Due to Hurricanes Harvey, Irma, and Maria (R24 Clinical Trial Optional)
- PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
- PA-19-052, NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-19-053, NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-19-054, NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-19-055, Research Project Grant (Parent R01 Clinical Trial Required)
- PA-19-056, Research Project Grant (Parent R01 Clinical Trial Not Allowed)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario